Press Releases
🇺🇸 FDA Page 12FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 133–144 of 212 articles
Alterity Therapeutics ATH434 Shows Reduced Functional Decline in Multiple System Atrophy Phase 2 Trial
Tempest Therapeutics Achieves Manufacturing Milestone for TPST-2003 CAR-T Cancer Treatment
NETRIS Pharma's NP137 Shows Promising Results in Pancreatic Cancer Phase 1b Trial Published in Nature
Neurosterix NTX-253 Phase 1 Schizophrenia Trial On Track for Q2 2026 Completion
Mabwell 9MW2821 Combination Therapy Data to Be Presented at ASCO 2026 for Urothelial Carcinoma Treatment
FDA Issues Complete Response Letter for Atara Biotherapeutics' EBVALLO Cancer Treatment, Triggering Securities Lawsuit
ImmunityBio (IBRX) Faces Securities Lawsuit After FDA Warning Letter Over Cancer Treatment Claims
NRx Pharmaceuticals Receives Positive FDA Feedback on Preservative-Free Ketamine Generic Drug Application
Labcorp Launches FDA-Approved PD-L1 Companion Diagnostic for KEYTRUDA Ovarian Cancer Treatment
Veloxis Pharmaceuticals' Pegrizeprument Receives FDA Orphan Drug Designation for Heart Transplant Rejection Prevention
Dupixent Becomes First Biologic Approved for Children Ages 2-11 with Chronic Spontaneous Urticaria
Capricor Therapeutics Presents Phase 3 HOPE-3 Trial Results for Deramiocel in Duchenne Muscular Dystrophy at AAN 2026